This article will be permanently flagged as inappropriate and made unaccessible to everyone. Are you certain this article is inappropriate? Excessive Violence Sexual Content Political / Social
Email Address:
Article Id: WHEBN0022843667 Reproduction Date:
Posizolid is an oxazolidinone antibiotic under investigation by AstraZeneca for the treatment of bacterial infections. At a concentration of 2 mg/L it inhibited 98% of all Gram-positive bacteria tested in vitro.[1]
: BAC
()
/ ()/ ()/
drug (, , , , )
United Kingdom, Sweden, GlaxoSmithKline, Neuroscience, London Stock Exchange
Linezolid, Posizolid, Tuberculosis, AstraZeneca, 30s